Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ClearPoint Neuro, Inc. (CLPT) had Revenue of $10.88M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$10.88M
Net Income	$-11.34M
Cost of Goods Sold	$4.17M
Gross Profit	$6.71M
Operating Expenses	$21.12M
Operating Income	$-10.24M
Non-Operating Income/Expense	$-1.13M
Pre-Tax Income	$-11.38M
Normalized Pre-Tax Income	$-11.38M
Income after Taxes	$-11.34M
Income from Continuous Operations	$-11.34M
Consolidated Net Income/Loss	$-11.34M
Normalized Income after Taxes	$-11.34M
EBIT	$-10.24M
EBITDA	$-8.82M
Weighted-Average Shares Outstanding (Basic)	30.17M
Weighted-Average Shares Outstanding (Diluted)	30.17M
Earnings per Share (EPS) (Basic)	$-0.38
Earnings per Share (EPS) (Diluted)	$-0.38
Balance Sheet Financials
Current Assets	$48.93M
Property, Plant, and Equipment	$2.99M
Long-Term Assets	$37.81M
Total Assets	$86.74M
Current Liabilities	$10.31M
Long-Term Debt	$50.23M
Long-Term Liabilities	$65.65M
Total Liabilities	$75.97M
Common Equity	$10.78M
Tangible Shareholders Equity	$-9.61M
Shareholders Equity	$10.78M
Common Shares Outstanding	30.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-14.98M
Cash Flow from Investing Activities	$-0.86M
Cash Flow from Financial Activities	$-0.84M
Beginning Cash	$46.97M
End Cash	$30.29M
Increase/Decrease in Cash	$-16.68M
Stock-Based Compensation	$4.49M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.74
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.82
Debt to Equity Ratio	4.66
Gross Margin	61.67%
Operating Margin	-94.15%
EBIT Margin	-94.15%
EBITDA Margin	--
Pre-Tax Profit Margin	-104.55%
Profit Margin	-104.20%
Free Cash Flow	$-15.84M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.47
Receiveable Turnover	1.30
Days Sales in Receivables	69.44
Return on Equity	-105.21%
Return on Tangible Equity	117.96%
Return on Assets	-13.07%
Return on Investments	-18.58%
Book Value Per Share	$0.35
Free Cash Flow per Share	$-0.53
Operating Cash Flow per Share	$-0.50

Data from Zacks Investment Research, Inc.